Page last updated: 2024-08-18

4-butyrolactone and Carcinogenesis

4-butyrolactone has been researched along with Carcinogenesis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cao, X; Chen, B; Chen, S; Li, C; Lu, H; Qi, X; Wen, P; Wu, L; Xu, A; Zhao, G1
Goswami, S; Sharma-Walia, N1

Other Studies

2 other study(ies) available for 4-butyrolactone and Carcinogenesis

ArticleYear
N-(3-oxo-acyl) homoserine lactone induced germ cell apoptosis and suppressed the over-activated RAS/MAPK tumorigenesis via mitochondrial-dependent ROS in C. elegans.
    Apoptosis : an international journal on programmed cell death, 2018, Volume: 23, Issue:11-12

    Topics: 4-Butyrolactone; Animals; Apoptosis; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Carcinogenesis; DNA Damage; Female; Germ Cells; MAP Kinase Signaling System; Mitochondria; Mutation; Oxidative Stress; ras Proteins; Reactive Oxygen Species; RNA Interference

2018
Crosstalk between osteoprotegerin (OPG), fatty acid synthase (FASN) and, cycloxygenase-2 (COX-2) in breast cancer: implications in carcinogenesis.
    Oncotarget, 2016, Sep-13, Volume: 7, Issue:37

    Topics: 4-Butyrolactone; Breast Neoplasms; Carcinogenesis; Caspase 9; Celecoxib; Cell Line, Tumor; Cyclooxygenase 2 Inhibitors; Fatty Acid Synthases; Female; Humans; Lipid Droplets; Lipid Metabolism; Molecular Targeted Therapy; Osteoprotegerin; Protein Binding; Receptor Cross-Talk; Signal Transduction; Tumor Microenvironment

2016